secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001625297-26-000008
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior announces $400M convertible senior notes offering due 2031; to repay term loan and repurchase up to $75M stock
--------------------------------------------------------------------------------

- $400M aggregate principal amount of convertible senior notes due 2031, with initial purchasers' option for additional $60M.
- Notes are senior unsecured, pay semi-annual interest, redeemable after March 20, 2029 if stock exceeds 130% of conversion price.
- Net proceeds used to repay $239M term loan plus $102M cash, repurchase up to $75M of stock from note purchasers, and general corporate purposes.
- Conversions settled in cash and possibly shares; noteholders can require repurchase on fundamental change.
- Offering is private under Rule 144A; notes and conversion shares not registered under Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/0001625297-26-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/indv-20260312.htm
  HTML page:      https://secwatch.observer/filing/0001625297-26-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer